Table 3.
Variable | IV Antiviral Efficacy in Reducing Hospital Stay by 1 d, ICER | ||
---|---|---|---|
25% | 50% | 75% | |
Seasonal Influenza Scenario | |||
IV antiviral cost of $100 per day | |||
PCR testing, then start IV antiviral agents | — | — | — |
Start IV antiviral agents, then PCR testing | 39,674 | 39,674 | 39,674 |
Give no IV antiviral agent | Dominated by start IV antiviral agents, then PCR testing | Dominated by start IV antiviral agents, then PCR testing | Dominated by start IV antiviral agents, then PCR testing |
Give IV antiviral agents | 802 | 800 | 790 |
IV antiviral cost of $500 per day | |||
Give no IV antiviral agent | — | — | — |
PCR testing, then start IV antiviral agents | 1733 | 1484 | 1301 |
Start IV antiviral agents, then PCR testing | 198,370 | 198,370 | 198,370 |
Give IV antiviral agents | 4266 | 4201 | 4236 |
IV antiviral cost of $1000 per day | |||
Give no IV antiviral agent | — | — | — |
PCR testing, then start IV antiviral agents | 6438 | 5473 | 5176 |
Start IV antiviral agents, then PCR testing | 396,739 | 396,739 | 396,739 |
Give IV antiviral agents | 8666 | 8596 | 8536 |
Pandemic Influenza Scenario With Twice the Seasonal Influenza Mortality | |||
IV antiviral cost of $100 per day | |||
PCR testing, then start IV antiviral agents | — | — | — |
Start IV antiviral agents, then PCR testing | 39,674 | 39,674 | 39,674 |
Give no IV antiviral agent | Dominated by start IV antiviral agents, then PCR testing | Dominated by start IV antiviral agents, then PCR testing | Dominated by start IV antiviral agents, then PCR testing |
Give IV antiviral agents | 789 | 794 | 797 |
IV antiviral cost of $500 per day | |||
Give no IV antiviral agent | — | — | — |
PCR testing, then start IV antiviral agents | 1499 | 1171 | 972 |
Start IV antiviral agents, then PCR testing | 198,370 | 198,370 | 198,370 |
Give IV antiviral agents | 4310 | 4202 | 4290 |
IV antiviral cost of $1000 per day | |||
Give no IV antiviral agent | — | — | — |
PCR testing, then start IV antiviral agents | 5554 | 4732 | 3876 |
Start IV antiviral agents, then PCR testing | 396,739 | 396,739 | 396,739 |
Give IV antiviral agents | 8506 | 8553 | 8571 |
ICER indicates incremental cost-effectiveness ratio (in US $ per QALY); IV, intravenous; PCR, polymerase chain reaction; QALY, quality-adjusted life-year.
In a patient aged 20 years (influenza prevalence, 10%) given 1 dose per day for a 5-day treatment course. Dash mark (—) indicates the best strategy compared with all other strategies.